Use in Specific Populations Lactation: Because of the potential for serious adverse reactions in breastfed infants from eribulin mesylate, advise women not to breastfeed during treatment with HALAVEN and for 2 weeks after the final dose
Genetic insights allow PlexusDx clinicians to personalize your dose, anticipate side effects, and recommend complementary therapiesall without raising your monthly medication cost
And while the latest update from the company is from a phase three trial, it still has a lot more work to do before it can start competing with Eli Lily and Novo Nordisk
Ryan, M.D., (2023) Semaglutide and cardiovascular outcomes in obesity without diabetes , New England Journal of Medicine, 389, pp
Why Such Different Results
Other data were analyzed using OriginPro 2021